Dr Lal Pathlabs

Dr Lal Pathlabs News

Pharma, Diagnostics stocks rally amid renewed Covid fears; Dr Lal PathLabs, Cipla shares jump up to 6%

Nifty Pharma index rises 2% as pharma, diagnostics stocks rally amid renewed Covid-19 outbreak fears. Dr Lal PathLabs, Vijaya Diagnostic…

December 21, 2022 13:36 IST

Nifty in short-term downtrend, but these two stocks may help investors pocket gains

The downside target is at 16858 (200 day EMA) once the support of 16958 is broken. We expect buying to…

April 28, 2022 08:18 IST

Vijaya Diagnostic IPO, Vijaya Diagnostic IPO price band

Vijaya Diagnostic Centre IPO opens next week; check grey market premium, price band, lot size, bid details

Vijaya Diagnostic Centre Rs 1,895-crore IPO will open for subscription on 1 September, at a price band of Rs 522-531…

August 26, 2021 11:19 IST

IPO, Vijaya Diagnostic Centre, public issue

Vijaya Diagnostic Centre IPO opens September 1; issue entirely an OFS

Vijaya Diagnostic Centre IPO will open for subscription on 1 September 2021 and close on 3 September.

August 25, 2021 10:55 IST

Krsnaa Diagnostics IPO share allotment: Check status online, grey market premium, listing day strategy

Krsnaa Diagnostics, whose IPO saw 64.40 times subscription, is likely to finalise the share allotment on Thursday, 12 August 2021.

August 12, 2021 11:54 IST

Dr Lal witnessed another quarter of strong growth with 128/41% YoY/QoQ growth.

Analyst Corner: ‘Hold’ on Dr Lal Pathlabs with DCF-based target price of Rs 3,405

However, considering recent rally in the stock price which has made valuations fair, we downgrade it to HOLD from Add.

August 6, 2021 01:00 IST

Krsnaa Diagnostics, IPO, Devyani International, Windlas Biotech, Exxaro Tiles

Krsnaa Diagnostics IPO opens August 4; check price band, grey market premium, IPO size, listing date

Krsnaa Diagnostics Rs 1,213-crore IPO will open for subscription on Wednesday, 4 August 2021, at a price band of Rs…

August 2, 2021 11:22 IST

Adding on to Mishra comments, Dr Lal also said that for the government to reach this magic figure of 2.5% of GDP by 2025, there needs to be additional spend of 1.2 lakh crore on heath every year.

‘To reach 2.5% of GDP spend, healthcare sector does not need a gradual but a quantum jump’

On the slow pace of vaccination Mishra did mention supply bottlenecks, vaccine hesitancy & ability to reach the arm as…

July 16, 2021 17:26 IST

Krsnaa Diagnostics files IPO papers with Sebi; firm receives heavy demand for PCR testing amid COVID-19

Krsnaa Diagnostics filed draft papers with the market regulator Securities and Exchange Board of India (Sebi) for an initial public…

May 17, 2021 14:40 IST

Indigo paints, ipo, initial public offer

Technical stock picks for 2021: Buy these 7 shares; charts signal as high as 30% rally next year

Over the past four decades, global equities have always generated positive returns in a year following US elections, wherein BSE…

December 24, 2020 14:38 IST

US Stocks, Wall Street, sectors, energy, travel, financials, U.S. presidential election, oil, dollar

Top stocks to buy post SEBI ruling: 5 high conviction midcap stocks with strong fundamentals, growth potential

The brokerage firm has prepared a basket of five high conviction midcap stocks which are fundamentally sound with good growth…

September 17, 2020 12:26 IST

Gayatri Projects’ JV wins contract worth Rs 1255 crore, shares surge 17 per cent

Dr Lal PathLabs shares gain today on expansion plans; up 80% since listing

Dr Lal PathLabs shares jumped over 2 per cent in the early trade on Friday on reports that the diagnostic…

Updated: June 10, 2016 16:05 IST

As Nifty ends below 8,900, these 65 stocks hit fresh 52-week high in Friday's trade

Muthoot Finance, Jubilant FoodWorks among 10 stocks that remained in focus in Monday’s trade

Muthoot Finance shares closed 8.72 per cent up at Rs 233.85 after the company reported 60.56 per cent rise in…

Updated: May 30, 2016 17:25 IST

Dr Lal PathLabs to acquire Delta Ria and Pathology

Diagnostic chain Dr Lal PathLabs today said it will fully acquire Delta Ria and Pathology while increasing its stake in…

May 27, 2016 20:48 IST

Dr Lal PathLabs Q4 net profit up 20 pct at Rs 34.44 crore

Diagnostic chain Dr Lal PathLabs today reported 19.79 per cent rise in consolidated net profit at Rs 34.44 crore for…

May 27, 2016 18:03 IST

Dr Lal, Alkem shares extend gains for second day after blockbuster listing

Share price of diagnostic chain Dr Lal PathLabs and drug major Alkem Laboratories surged 8.43 per cent and 10.16 per…

December 24, 2015 16:36 IST

Alone and loving it: Lal Pathlabs and five other stock singles

After the success of Dr Lal Pathlabs, we take a look at some companies which are the only listed ones…

Updated: December 23, 2015 16:20 IST

Dr Lal PathLabs surges 52%, Alkem Labs gains 31% on market debut

Alkem Laboratories shares opened 31.42 per cent up from its issue price of Rs 1,050 on BSE. Dr Lal Pathlabs…

Updated: December 23, 2015 17:01 IST

After Alkem and Dr Lal IPOs, Narayana Hrudayalaya set to hit market next week

Narayana Hrudayalaya is set to hit Dalal Street with its initial public offer (IPO) on December 17.

Updated: December 11, 2015 11:01 IST

IPOs of Dr Lal PathLabs, Alkem fully subscribed

Despite volatility in the secondary markets, initial public offerings (IPO) of Alkem Laboratories and Dr Lal PathLabs managed to get…

December 10, 2015 00:11 IST

Dr Lal PathLabs subscribed 0.65 times

The initial public offering (IPO) of Dr Lal PathLabs was subscribed 0.65 times on the first day of three day…

December 9, 2015 00:13 IST

Dr Lal PathLabs IPO hits market: Should you subscribe or avoid?

Dr Lal PathLabs’ price band for the offer has been fixed at Rs 540-550 per share and the allotment to…

Updated: December 9, 2015 09:11 IST

Loading…

Something went wrong. Please refresh the page and/or try again.